These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28344559)

  • 21. Endothelin mediates some of the renal actions of acutely administered angiotensin II.
    Riggleman A; Harvey J; Baylis C
    Hypertension; 2001 Jul; 38(1):105-9. PubMed ID: 11463769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of angiotensin-II on lipolysis in humans.
    Townsend RR
    Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of angiotensin-(1-7) in gastroprotection against stress-induced ulcerogenesis. The involvement of mas receptor, nitric oxide, prostaglandins, and sensory neuropeptides.
    Magierowski M; Jasnos K; Pawlik M; Krzysiek-Maczka G; Ptak-Belowska A; Olszanecki R; Kwiecien S; Korbut R; Brzozowski T
    J Pharmacol Exp Ther; 2013 Dec; 347(3):717-26. PubMed ID: 24049058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide inhibition and renal alterations.
    Jover B; Mimran A
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
    Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
    Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High glucose increases expression of cyclooxygenase-2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells.
    Aljofan M; Ding H
    J Cell Physiol; 2010 Mar; 222(3):669-75. PubMed ID: 19950211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
    Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sodium depletion on the role of AT1- and alpha-adrenergic receptors in the regulation of forearm vascular tone in humans.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    J Hypertens; 1999 Feb; 17(2):229-35. PubMed ID: 10067792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II.
    Ruskoaho H; Leskinen H; Magga J; Taskinen P; Mäntymaa P; Vuolteenaho O; Leppäluoto J
    J Mol Med (Berl); 1997; 75(11-12):876-85. PubMed ID: 9428620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhibition of nitric oxide synthesis on the cardiovascular and endocrine responses to hemorrhage in conscious rabbits.
    Chiu T; Reid IA
    Hypertens Res; 1995 Mar; 18(1):55-61. PubMed ID: 7584911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interactions between the renin-angiotensin system, nitric oxide and endothelin].
    Dussaule JC; Tharaux PL; Boffa JJ; Ardaillou R; Chatziantoniou C
    Nephrologie; 1998; 19(7):437-41. PubMed ID: 9857381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
    Qiu C; Baylis C
    Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
    J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
    Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA
    Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.